Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer
Phase III
· Site: SITE005 (FRA) (Dr. Muller)
· consented 2023-03-26
Adverse events
5
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Grade 1 Rash — outcome: RECOVERED/RESOLVED; onset 2023-06-22 (study day 80); relationship: not assessed
mild
assessed
2026-08-18
Grade 1 Colitis — outcome: RECOVERED/RESOLVED; onset 2023-07-14 (study day 102); relationship: not assessed
mild
assessed
2026-08-18
Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2023-11-03 (study day 214); relationship: not assessed
mild
assessed
2026-08-18
Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2024-04-11 (study day 374); relationship: N
mild
assessed
2026-08-18
Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2024-11-10 (study day 587); relationship: N
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.